RFK Jr. proposes FDA look the other way on unproven peptides, report says
FDA scientists said none of the popular drugs have been proven safe or effective.
Robert F. Kennedy Jr. has proposed that the Food and Drug Administration (FDA) should relax regulations surrounding unproven peptide drugs, according to a report. This comes as part of the Make America Healthy Again movement, of which Kennedy is a prominent supporter. Despite FDA scientists expressing concerns that these drugs have not undergone adequate testing to ensure their safety and effectiveness, the FDA has filed an Interim Access Policy for review by the White House.
This policy, as reported by The Associated Press, would grant the FDA "enforcement discretion" on certain peptide drugs, effectively allowing them to choose not to enforce existing restrictions. This move would provide an assurance to specialty pharmacies that are eager to begin producing these drugs, ensuring they will not face penalties from the agency.
However, the Department of Health and Human Services, which oversees the FDA, has declined to comment on the proposal.
Written by urgent.news from Ars Technica's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
